ID: ALA3739990

Max Phase: Preclinical

Molecular Formula: C22H16O5

Molecular Weight: 360.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1c(O)cc2oc(-c3ccc(-c4ccccc4)cc3)cc(=O)c2c1O

Standard InChI:  InChI=1S/C22H16O5/c1-26-22-17(24)12-19-20(21(22)25)16(23)11-18(27-19)15-9-7-14(8-10-15)13-5-3-2-4-6-13/h2-12,24-25H,1H3

Standard InChI Key:  YZYTUGGFILDFRY-UHFFFAOYSA-N

Associated Targets(Human)

Receptor-type tyrosine-protein phosphatase S 105 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 360.37Molecular Weight (Monoisotopic): 360.0998AlogP: 4.55#Rotatable Bonds: 3
Polar Surface Area: 79.90Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.10CX Basic pKa: CX LogP: 4.50CX LogD: 4.02
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.56Np Likeness Score: 0.98

References

1. Lee HS, Ku B, Park TH, Park H, Choi JK, Chang KT, Kim CH, Ryu SE, Kim SJ..  (2016)  Identification of novel protein tyrosine phosphatase sigma inhibitors promoting neurite extension.,  26  (1): [PMID:26602279] [10.1016/j.bmcl.2015.11.026]

Source